AAVM yields 1.97% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, AAVM + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AAVM + JNJ for your $10,000?
AAVM is a fund-of-funds that seeks to provide long-term capital appreciation through a multi-factor approach. The fund comprises four other ETFs from Alpha Architect, each targeting specific exposures: US value, developed ex-US value, US momentum, and developed ex-US momentum. These underlying funds are managed using a multi-step, quantitative methodology to identify equities with the highest relative momentum (for the momentum ETFs) or potential for capital appreciation (for the value ETFs). AAVM's adviser allocates the portfolio across the four underlying ETFs using a proprietary model that assigns greater weight to the ETF with higher relative momentum. The portfolio is generally rebalanced quarterly, although it may be rebalanced more frequently at the adviser's discretion. Prior to Jan. 31, 2022, AAVM tracked the Alpha Architect Value Momentum Trend Index. Before Jan. 31, 2025, the fund was named Alpha Architect Value Momentum Trend ETF and traded under the ticker VMOT.
Full AAVM Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.